SANDS ARTHUR T has filed 4 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 562500 shares of Nurix Therapeutics, Inc. ($NRIX) on February 10, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 10, 2026 | Nurix Therapeutics, Inc. | $NRIX | SANDS ARTHUR T | President, CEO | A | Employee Stock Option (right to buy) | 562500 | $0.00 | 562,500.0000 | 102,843,012 | 9999.99% | 0.55% |
| Feb. 11, 2025 | Nurix Therapeutics, Inc. | $NRIX | SANDS ARTHUR T | President, CEO | A | Employee Stock Option (right to buy) | 450000 | $0.00 | 450,000.0000 | 75,886,817 | 9999.99% | 0.59% |
| Feb. 13, 2024 | Nurix Therapeutics, Inc. | $NRIX | SANDS ARTHUR T | President, CEO | A | Employee Stock Option (right to buy) | 800000 | $0.00 | 800,000.0000 | 54,337,901 | 9999.99% | 1.47% |
| Feb. 14, 2023 | Nurix Therapeutics, Inc. | $NRIX | SANDS ARTHUR T | President, CEO | A | Employee Stock Option (right to buy) | 448000 | $0.00 | 448,000.0000 | 48,607,990 | 9999.99% | 0.92% |